Deoxymethoxetamine
![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
PubChem CID | |
UNII | |
Chemical and physical data | |
Formula | C15H21NO |
Molar mass | 231.339 g·mol−1 |
3D model (JSmol) | |
| |
InChI
|
Deoxymethoxetamine (3'-methyl-2-oxo-PCE, DMXE, 3D-MXE) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects. It is an analogue of methoxetamine where the 3-methoxy group has been replaced by methyl. It has been sold online since around October 2020, and was first definitively identified by a forensic laboratory in Denmark in February 2021.[1][2]
See also[]
- 3-Methyl-PCP
- 3-Methyl-PCPy
- Hydroxetamine
- Fluorexetamine
- Methoxieticyclidine
- MXiPr
References[]
- ^ "Alert from NDEWS Web Monitoring team: Increases in Reddit discussions of DMXE October 2020–March 2021". National Drug Early Warning System. University of Florida, funded by the National Institute on Drug Abuse (28). 26 March 2021.
- ^ Skinnider M, Wang F, Pasin D, Greiner R, Foster L, Dalsgaard P, Wishart DS (2021). "A Deep Generative Model Enables Automated Structure Elucidation of Novel Psychoactive Substances". ChemRxiv. Cambridge: Cambridge Open Engage.
Categories:
- Arylcyclohexylamines
- Designer drugs
- Dissociative drugs
- Secondary amines
- Ketones
- Nervous system drug stubs